Paricalcitol Generics Suppliers & Bulk Manufacturers
Available Forms: Capsules and Injection
Available Strengths: Capsules:1mcg, 2mcg, 4 mcg & Injection: 2mcg/mL , 5mcg/mL
Reference Brands: Zemplar®(US &EU)
Category: Nephrology
Paricalcitol (Zemplar®) is a selective vitamin D receptor activator used to manage secondary hyperparathyroidism in CKD patients, available as oral capsules and IV injection. Approved in both the EU and US, it offers targeted PTH control with a lower risk of hypercalcemia and hyperphosphatemia. Suitable for hospital tenders, licensing, and distribution in the global renal care market.
Product Description:
Paricalcitol, marketed as Zemplar®, is a selective vitamin D receptor activator used to treat secondary hyperparathyroidism in patients with chronic kidney disease (CKD), both on dialysis (stage 5) and in pre-dialysis stages (3–4). It effectively lowers parathyroid hormone (PTH) levels while minimizing the risk of hypercalcemia and hyperphosphatemia. Available as oral capsules (1 mcg, 2 mcg, 4 mcg) and IV injection (2 mcg/mL, 5 mcg/mL), Paricalcitol is approved in both the US (FDA) and EU (EMA). It is a key therapeutic in nephrology and an excellent B2B opportunity for licensing, distribution, and hospital-based partnerships in regulated markets.
Paricalcitol Generics — third party manufacturing & bulk supply
Paricalcitol Generics is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Paricalcitol Generics is supplied as Capsules and Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Paricalcitol Generics listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Paricalcitol Generics →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Atrasentan Hydrochloride
Strength:
0.75 mg, 1.25 mg, 10 mg
Form: Tablets
Reference Brands: Xinlay (USA/EU), Vanrafia (USA/LATAM)
View Details
Tiopronin
Strength:
100 mg, 200 mg , 300 mg
Form: Tablets, Capsules
Reference Brands: Thiola (USA), Mercaptamine (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
